Trial · NCT01434342

Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients

NCT01434342, Early phase 1, Completed, Wake Forest University Health Sciences; results first posted 2017-06-06

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients. Trials, record NCT01434342. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01434342

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
NCT number: NCT01434342
Status: Completed
Phases: Early phase 1
Enrollment: 146 participants, actual
Lead sponsor: Wake Forest University Health Sciences
Conditions: Lung Cancer, Tobacco Use Disorder, Breast Cancer, Colorectal Cancer, Prostate Cancer
Interventions: Nicotine Replacement Patch
First posted: 2011-09-14
Last updated: 2021-09-28
Results first posted: 2017-06-06

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Feasibility of a Smoking Cessation Intervention Among Cancer Patients	24 Weeks	The primary feasibility measures are retention and adherence. This outcome, retention, is the percentage of patient who remain in the study for 24 weeks.
Primary	Adherence	24 weeks	Adherence is measured by the percentage of randomized participants who have a Quitline call. Note that this outcome is only defined for the Intervention arm

Source ClinicalTrials.gov

Outcomes2

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Feasibility of a Smoking Cessation Intervention Among Cancer Patients	24 Weeks	All randomized participants	Participants	COUNT_OF_PARTICIPANTS
PRIMARY	Adherence	24 weeks	All randomized participants	Participants	COUNT_OF_PARTICIPANTS

Source ClinicalTrials.gov

Results by group3

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Value	Units
Feasibility of a Smoking Cessation Intervention Among Cancer Patients	Arm I - Quitline	55	Participants
Feasibility of a Smoking Cessation Intervention Among Cancer Patients	Arm II - Usual Care	33	Participants
Adherence	Arm I - Quitline	81	Participants

Source ClinicalTrials.gov

Participant flow6

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	Quitline	98
Overall Study	STARTED	Usual Care	48
Overall Study	COMPLETED	Quitline	50
Overall Study	COMPLETED	Usual Care	31
Overall Study	NOT COMPLETED	Quitline	48
Overall Study	NOT COMPLETED	Usual Care	17

Source ClinicalTrials.gov

Adverse events98

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anorexia	Psychiatric disorders	Arm I - Quitline	3	75	5
other	Anorexia	Psychiatric disorders	Arm II - Usual Care	2	37	3
other	Anxiety	Psychiatric disorders	Arm I - Quitline	35	75	74
other	Anxiety	Psychiatric disorders	Arm II - Usual Care	15	37	27
other	Chest pain cardiac	Cardiac disorders	Arm I - Quitline	6	75	9
other	Chest pain cardiac	Cardiac disorders	Arm II - Usual Care	3	37	4
other	Constipation	Gastrointestinal disorders	Arm I - Quitline	21	75	41
other	Constipation	Gastrointestinal disorders	Arm II - Usual Care	9	37	16
other	Cough	Respiratory, thoracic and mediastinal disorders	Arm I - Quitline	10	75	15
other	Cough	Respiratory, thoracic and mediastinal disorders	Arm II - Usual Care	5	37	9

1 to 10 of 98Source ClinicalTrials.gov

See all 98 adverse events

Adverse event totals6

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	Arm I - Quitline
Total, all-cause mortality	Arm II - Usual Care
Total, other adverse events	Arm I - Quitline	61	75
Total, other adverse events	Arm II - Usual Care	33	37
Total, serious adverse events	Arm I - Quitline	14	75
Total, serious adverse events	Arm II - Usual Care	5	37

Source ClinicalTrials.gov

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

Project	Title	Principal investigators	Organization	Funder	Fiscal years
U10CA081851	Comprehensive Cancer Center of Wake Forest COOP Research Base	SHAW, EDWARD G	WAKE FOREST UNIVERSITY HEALTH SCIENCES	NATIONAL CANCER INSTITUTE	1999 to 2013

Source NIH RePORTER

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison	Source
Arm I - Quitline vs Arm II - Usual Care: Feasibility of a Smoking Cessation Intervention Among Cancer Patients	Trial comparisons
Arm I - Quitline vs Arm II - Usual Care: serious adverse events	Trial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01434342

GET https://conductscience.org/api/trials/v1/NCT01434342/events?page=2

API reference For AI assistants